Jonathan Jay Mazelsky - 04 May 2023 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)

Role
President and CEO, Director
Signature
/s/ Lily J. Lu, Attorney-in-Fact for Jonathan Jay Mazelsky
Issuer symbol
IDXX
Transactions as of
04 May 2023
Net transactions value
+$99,826
Form type
4
Filing time
05 May 2023, 18:00:22 UTC
Previous filing
16 Feb 2023
Next filing
19 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IDXX Common Stock Options Exercise $99,826 +560 +0.77% $178.26 73,301 04 May 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IDXX Incentive Stock Option (right-to-buy) Options Exercise -560 -100% 0 04 May 2023 Common Stock 560 $178.26 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 14.7030 shares purchased under the Issuer's Employee Stock Purchase Plan on March 31, 2023.
F2 Grant of option to buy shares of Issuer common stock that became exercisable on the fifth anniversary of the date of grant.
F3 Not applicable.